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The inherent biocompatibility of fibrin hydrogels makes them an attractive material for 
use in a wide range of tissue engineering applications. Despite this, their relatively low 
stiffness and high compliance limits their potential for certain orthopaedic applications. 
Enhanced mechanical properties are desirable so as to withstand surgical handling and 
in vivo loading after implantation and additionally, can provide important cues to cells 
seeded within the hydrogel. Standard methods used to enhance the mechanical 
properties of biological scaffolds such as chemical or thermal crosslinking cannot be 
used with fibrin hydrogels as cell seeding and gel formation occurs simultaneously. The 
objective of this study was to investigate the use of plastic compression as a means to 
improve the mechanical properties of chondrocyte-seeded fibrin hydrogels and to 
determine the influence of such compression on cell viability within these constructs. It 
was found that the application of 80% strain to fibrin hydrogels for 30 minutes (which 
resulted in a permanent strain of 47.4%) produced a 2.1-fold increase in the subsequent 
compressive modulus. Additionally, chondrocyte viability was maintained in the 
plastically compressed gels with significant cellular proliferation and extracellular 
matrix accumulation observed over 28 days of culture. In conclusion, plastic 
compression can be used to modulate the density and mechanical properties of cell-
seeded fibrin hydrogels and represents a useful tool for both in theatre and in vitro 
tissue engineering applications. 
1. Introduction
Fibrin is a polymeric protein that acts with platelets to form a thrombus or blood clot 
and as such constitutes an intrinsic scaffold for repair and regeneration (Orlando et al., 
2012). Accordingly, fibrin hydrogels are an attractive material for use in tissue 
engineering; possessing inherent biocompatibility, biodegradability and suitable 
interaction with cells and other macromolecules (Sierra, 1993, Bensaïd et al., 2003, 
Ahmed et al., 2008, Breen et al., 2009). As such fibrin has been used as a scaffold to 
deliver cells, drugs and therapeutic molecules in a wide range of tissue engineering 
applications (Albes et al., 1994, Eyrich et al., 2007, Willerth et al., 2007, Pelaez et al., 
2009, Bhang et al., 2007b, Ahearne et al., 2011, Hyatt et al., 2010, Steward et al., 2012, 
Deponti et al., 2012, O'Heireamhoin et al., 2012, Thorpe et al., 2012). However, 
despite these qualities, the relatively weak mechanical properties of fibrin hydrogels 
may limit their use in orthopaedic applications (Hokugo et al., 2006, Mol et al., 2005, 
Jockenhoevel et al., 2001). The mechanical properties of scaffolds used in tissue 
engineering are important for establishing appropriate mechanical support to cells 
within load bearing defects and facilitating manipulation of these constructs prior to 
implantation (Rosso et al., 2005). Additionally, several studies have shown that the 
stiffness of a substrate can direct cellular activity such as attachment, migration and 
differentiation (Engler et al., 2004, Engler et al., 2006, Yeung et al., 2005, Haugh et al., 
2011b, Murphy et al., 2012). Thus mechanical properties take on further importance. 
The mechanical weakness of fibrin hydrogels arises from the highly hydrated nature of 
these gels (i.e. the low protein to water ratio). Crosslinking techniques are commonly 
used to improve the properties of protein based biomaterials, however these techniques 
can leave behind cytotoxic residues (Haugh et al., 2011b, Weadock et al., 1983). 
Additionally as gelation and cell seeding typically take place concurrently during 
fabrication of hydrogels, the use of cytotoxic crosslinking reagents would not be viable. 
Recently it has been shown that dense collagen hydrogels can be produced through 
unconfined plastic compression (PC), which results in significant exclusion of water 
from the hydrogels and a large increase in strength (Brown et al., 2005, Abou Neel et 
al., 2006, Bitar et al., 2007). The uncomplicated nature of this process, coupled with its 
ability to rapidly improve mechanical properties while having no substantial effect on 
cell viability within the gels, also make it practical for incorporation in cell delivery 
techniques in theatre (Brown et al., 2005). The results of these studies suggest that 
plastic compression represents a promising technique for improving the properties of 
fibrin hydrogels due to their structural similarities to collagen-based hydrogels. 
Despite the widespread use of fibrin hydrogels, their mechanical properties restrict their 
application in tissue engineering. Plastic compression has been shown to improve the 
properties of collagen gels but its effects on fibrin-based hydrogels have yet to be 
evaluated. Therefore, the overall goal of this study was to investigate the feasibility of 
improving the mechanical properties of fibrin gels through the use of plastic 
compression. The specific objectives were to determine 1) the increase in stiffness of 
fibrin hydrogels following plastic compression, 2) the stability of this increase over 
time and 3) the effect of plastic compression on chondrocyte viability and cartilaginous 
matrix production within the hydrogels. 
2. Materials and Methods
2.1 Cell Isolation and Preparation of Fibrin Gel Constructs 
The effects of plastic compression on cell viability were assessed using porcine 
chondrocytes. Full-depth slices of cartilage were harvested under aseptic conditions 
from the femoral condyles of 3 four month old porcine donors (~50 kg), and rinsed 
thoroughly with PBS containing 200 U/mL penicillin, 200 µg/mL streptomycin 
(GIBCO, Biosciences, Dublin, Ireland). Chondrocytes were isolated from cartilage 
slices through incubation with DMEM/F12 containing collagenase type II (0.5 mg/mL) 
(all from Sigma–Aldrich, Arklow, Ireland) for 18 h under constant rotation at 37°C. 
The cell suspension was passed through a 40 µm pore-size cell sieve (BD Falcon, 
Unitech, Ireland) and the filtrate centrifuged and rinsed with PBS twice. Cells were 






 T-flasks (Sarstedt, Neumbrecht,
Germany) and expanded (1:2 ratio) to passage one (P1). Cell number and viability were 
determined using a haemacytometer and 0.4% trypan blue staining. Isolated 
chondrocytes from all joints were pooled and maintained in DMEM/F-12 (Sigma–
Aldrich, Dublin, Ireland) supplemented with 10% v/v fetal bovine serum (FBS) and 
100 U/mL penicillin, 100 µg/mL streptomycin (GIBCO, Biosciences, Dublin, Ireland) 
during the expansion phase. 
Following isolation and expansion to P1, chondrocytes from the three donors were 
pooled, then suspended at 7.5x10
6
 cells/mL in a 40 mg/mL solution of fibrinogen in
DMEM/F-12 (Sigma-Aldrich, Arklow, Ireland). In order to fabricate the gels, 10 U/mL 
thrombin (0.5 U thrombin per mg of fibrinogen; Sigma-Aldrich, Arklow, Ireland) was 
added to the fibrinogen/cell suspension (Zhao et al., 2008). The resulting solution was 
mixed by pipette and cast in a stainless steel mould and left to clot at 37°C for 10 min to 
produce 3 mm thick cylindrical constructs (Ø5 mm, 4.4x10
5
 cells). Fibrin gel constructs
were maintained in DMEM/F-12 (Sigma–Aldrich, Arklow, Ireland) supplemented with 
10% v/v fetal bovine serum (FBS) and 100 U/mL penicillin, 100 µg/mL streptomycin 
(GIBCO, Biosciences, Dublin, Ireland), 1 mg/mL insulin and 50 mg/mL ascorbic acid 
(Sigma–Aldrich, Arklow, Ireland). Aprotinin (Sigma-Aldrich, Arklow, Ireland) was 
also added to the media at a concentration of 0.0875 IU/mL to prevent degradation of 
the fibrin constructs. Medium was changed every 3-4 days. 
2.2 Plastic compression 
Fibrin gel constructs were compressed using a bioreactor system developed in our 
laboratory as previously described (Thorpe et al., 2010, Haugh et al., 2011a). 
Unconfined compression was applied using an impermeable platen to 80% strain; this 
deformation was then maintained for 30 min in a humidified atmosphere at 37°C and 
5% CO2. After the application of plastic compression the constructs were placed in 6 
well plates containing supplemented CDM and maintained for 28 days in standard cell 
culture conditions. 
2.3 Mechanical Testing 
Unconfined compression testing with impermeable, un-lubricated platens was used to 
determine the effect of plastic compression on the modulus of fibrin gels. Mechanical 
testing of the samples was carried out using a mechanical testing machine (Z050, 
Zwick/Roell, Germany) fitted with a 5 N S-type load cell and all testing was carried out 
in a bath of PBS. The accuracy of this system was as follows: crosshead speed had 0.05 
% accuracy of the set speed and the drive systems had a travel resolution of 0.0828 µm 
with positioning resolution accuracy ± 2 µm. The S-type load cell used in this study 
was calibrated in tension and compression with a 5 N load capacity and the force 
readings were accurate to within 0.06 % of resultant force. Testing was conducted at a 
strain rate of 10%/min and the modulus was defined as the slope of a linear fit to the 
stress-strain curve over 2-5% strain (Haugh et al., 2009, Haugh et al., 2011b). The 
height of the samples was calculated using a preload threshold (5 mN) to establish 
contact between the sample and the upper platen before initiation of the compression 
tests, this data was used to calculate the level of plastic compression at days 0 and 28. 
2.4 Quantitative Biochemical Analysis 
Samples were harvested at days 0 and 28. At each time point the samples were weighed 
and their dimensions measured before being frozen (-85°C) for analysis at a later date. 
Prior to analysis, samples were thawed and digested with 125 μg/mL papain in 0.1 M 
sodium acetate, 5 mM L-cysteine HCL, 0.05 M EDTA (all Sigma-Aldrich, Arklow, 
Ireland), pH 6.0 at 60°C under constant rotation for 18 hr. Cell number was evaluated 
using the Hoechst 33258 DNA assay, which fluorescently labels double-stranded DNA 
(Sigma-Aldrich, Germany), according to a previously published protocol and using calf 
thymus DNA (Sigma-Aldrich, Arklow, Ireland) as a standard (Kim et al., 1988). 
Sulphated glycosaminoglycan (sGAG) content was measured using the 
dimethylmethylene blue dye-binding assay (Blyscan, Biocolor Ltd., Northern Ireland) 
using shark derived chondroitin sulphate (Sigma-Aldrich, Arklow, Ireland) as a 
standard. All assays were carried out with a minimum of three samples analysed in 
triplicate for each group at every time point. 
2.5 Confocal Microscopy 
Cell viability within the compressed and control samples was assessed using a 
LIVE/DEAD assay kit (Invitrogen, Biosciences, Dublin, Ireland) at 1 and 28 days. 
Fibrin gel constructs were first washed in PBS and then placed in a calcein 
acetoxymethyl and ethidium homodimer-1 solution for 1 hour to stain live and dead 
cells. The samples were then rinsed three times in PBS and images of the constructs 
were captured using a confocal microscope (LSM510 META, Carl Zeiss, Germany). 
Confocal scans were taken as close to the centre of the hydrogel as it was possible to 
focus (approx. 100 µm from the surface). 
2.6 Statistical Analysis 
Results are expressed as mean ± standard deviation. Two-way analysis of variance 
(ANOVA), with time and gel type (compressed/uncompressed) as the independent 
factors, followed by pairwise multiple comparison procedures (Holm-Sidak test) was 
used depending on the number of variables to evaluate the results from the quantitative 
biochemical assays. Statistical significance was declared at p≤0.05. 
3. Results
3.1 The effect of plastic compression on construct dimensions and mechanical 
properties 
At day 0 it can be seen that 80% compression resulted in a plastic (or permanent) 
deformation of 47.4% such that constructs were now 52.6% of their original thickness. 
By day 28 the samples had recovered (or had swollen to) to 69.8% of their original 
thickness (or 30.2% plastic strain, Fig. 1A). The compressive modulus of the plastically 
compressed gels was significantly greater than the control group at both time points and 
the modulus of both groups increased over the 28 day incubation period (Fig. 1B, Table 
1). At day 0 plastic compression resulted in a 2.12-fold increase in compressive 
modulus over uncompressed gels (5.95 vs. 12.63 kPa; p<0.05). Despite the change in 
deformation and elaboration of matrix (see below), plastic deformation still had a 
beneficial effect on construct properties in the long-term, with these constructs still 1.44 
times stiffer than the uncompressed gels after 28 days of culture (24.68 vs. 35.74 kPa; 
p<0.05, Table 1). 
3.2 The effect of plastic compression on cell viability and matrix deposition 
Live dead staining was used to asses cell viability in both groups at day 0 and 28 (Fig. 
2).  No significant differences in cell viability can be seen between the uncompressed 
and compressed at either time point. Additionally a change in cell morphology was 
observed in both groups; at day 0 the cells appear rounded within the gels, while by day 
28 cells had adopted a spread morphology consistent with cells that have attached to the 
surrounding matrix. 
Cell number, as measured by DNA content, can be seen to increase significantly over 
the 28 day incubation period in both groups (Fig. 3A, p<0.05). By day 28, DNA content 
is significantly higher in the uncompressed constructs; however DNA content in the 
plastically compressed group still increases from day 0 to 28 indicating significant cell 
proliferation within the constructs. The sGAG content within the gels increased 
significantly over time in both groups (Fig. 3B&C, p<0.001). Total sGAG content was 
significantly greater in the uncompressed group, however when sGAG content was 
normalised to DNA there was no significant difference between compressed and 
uncompressed constructs. 
Discussion 
Plastic compression has been previously shown to increase the compressive properties 
of cell seeded collagen gels (Brown et al., 2005, Abou Neel et al., 2006, Bitar et al., 
2007). This method is both effective and uncomplicated in its application; however its 
potential to enhance the properties of fibrin hydrogels has not been explored. With this 
in mind, we sought to investigate the feasibility of enhancing the mechanical properties 
of fibrin gels through the use of plastic compression and to determine its effect on the 
viability of cells seeded within them. We found that the application of plastic 
compression to fibrin hydrogels produced an initial 2.1-fold increase in compressive 
modulus. A significant difference in modulus between uncompressed and plastically 
compressed gels was maintained over 28 days of culture with compressed gels still 1.4 
stiffer than the uncompressed gels at this time point. Additionally, plastic deformation 
and cellular viability was maintained in the plastically compressed gels with significant 
cellular proliferation and extracellular matrix accumulation over 28 days. Taken 
together, these results indicate that the application of plastic compression to fibrin 
hydrogels represents a useful tool for both in theatre and in vitro tissue engineering 
applications. 
In this study, we investigated the effects of plastic compression on both the 
mechanical properties of fibrin hydrogels and the viability of cells within them. The 
effect of altering fibrinogen solution concentration prior to gelation on the strength and 
durability of cell seeded fibrin hydrogels has been extensively investigated in previous 
studies (Jeon et al., 2005, Bhang et al., 2007a, Zhao et al., 2008). However, this 
approach has limitations owing to the solubility of fibrinogen. Therefore in this study, 
we sought to use plastic compression to effectively increase gel density post gelation, 
bypassing limitations due to solubility. The starting concentration of fibrinogen used in 
this study was chosen to be relevant for surgical applications as it is similar to the 
concentrations of commercially available surgical fibrin sealants (Hyatt et al., 2010). 
Higher fibrinogen concentrations have been used previously in the literature (Hyatt et 
al., 2010, Jeon et al., 2005), however we have found that it is increasingly difficult to 
get fibrinogen into solution at higher concentrations, which in turn makes it more 
difficult to sterile filter the solution and to produce a homogenous construct post-
gelation. Therefore, we sought to investigate the effect of plastic compression of fibrin 
hydrogels using a fibrinogen solution concentration which was both similar to products 
approved for surgical use and that facilitated the fabrication of a sterile homogeneous 
gel. In this study the effect of plastic compression on mechanical properties and cell 
viability was investigated at 0 and 28 day time points. These time points were chosen as 
they allowed the initial effects of plastic compression to be evaluated in addition to the 
stability of the induced changes to be determined over an extended culture period. The 
disadvantage of this approach is that it provides no information on changes in 
deformation and cellular activity between days 0 and 28. However, given that plastic 
compression did not appear to have a significant impact on the viability of the cells 
within the fibrin hydrogels over the 28 day time period, the time points used in this 
study were sufficient to address the aims of the study. 
Mechanical testing showed that plastic compression resulted in an initial 2.14 
fold increase in compressive modulus which was reduced to a 1.4 fold increase after 28 
days of culture (Fig. 1). The initial effect of plastic compression on construct 
mechanical properties is important in applications such as articular cartilage 
regeneration, where the gels will be loaded shortly after implantation. While plastic 
compression has been used previously to enhance the properties of collagen gels, its 
effects on compressive modulus were not investigated, making a comparison to our 
results difficult (Brown et al., 2005, Abou Neel et al., 2006, Bitar et al., 2007). 
Additionally, there are differences in the gelation mechanisms between collagen and 
fibrin hydrogels. Fibrin hydrogels are formed when fibrinogen is crosslinked 
enzymatically by thrombin, while collagen gels self-assemble to form a network of 
entangled but non-covalently linked fibrils (Breen et al., 2009, Abou Neel et al., 2006). 
In both cases any increase in mechanical properties is the result of an increase in 
protein density as fluid is driven out of the gels during plastic compression. 
The temporal increase in sGAG content within cell seeded fibrin hydrogels 
found in this study is comparable to previous studies (Eyrich et al., 2007). We found a 
sGAG content in the range of 112-152 ng/construct at 28 days using porcine 
chondrocytes (4.4x10
5
 cells), while Eyrich et al. (2007) found a sGAG content of
approximately 250 ng/construct at 35 days using bovine chondrocytes (5x10
5
 cells).
This variation in sGAG content is within a range that may be accounted for by the 
difference in the species of cell source, time point of analysis and construct dimensions 
used in the two studies. Using chondrocytes seeded onto polylactide/fibrin gel 
composites, Zhao et al. (2009) reported an sGAG content of approximately 1.7 mg/cm
3 
at day 21, which compares well to our value of 2.7 and 2.8 mg/cm
3
 at 28 days for
uncompressed and compressed fibrin gels respectively (Table 1, Zhao et al. 2009). 
While levels of sGAG synthesis were comparable in compressed and uncompressed 
constructs, chondrocytes proliferation was lower in compressed hydrogels. Previous 
studies have reported that cellular proliferation within fibrin hydrogels decreases with 
increases in fibrinogen concentration (Cox et al., 2004, Ho et al., 2006, Duong et al., 
2009, des Rieux et al., 2009), which may be due to reduced permeability in these higher 
fibrinogen concentration constructs (Chiu et al., 2012). A similar mechanism may 
explain the lower levels of chondrocyte proliferation in the compressed hydrogels. 
The results of this study show that plastic compression can be used to produce a 
stable increase in the fibrin concentration of fibrin hydrogels resulting in a significant 
increase in mechanical properties. The improvement in mechanical properties achieved 
through plastic compression increases the suitability of fibrin hydrogels for ‘in theatre’ 
applications and alternatively could also reduce the length of in vitro culture needed to 
attain load-bearing properties prior to implantation. Additionally, while there was a 
significant difference in cell number between the compressed and uncompressed groups 
at 28 days, the substantial increases in cell number and sGAG content observed within 
the compressed hydrogels over the 28 day culture period demonstrates that plastic 
compression had negligible effects on cellular viability and biosynthesis within the 
fibrin gels. Previous studies have shown that the release of therapeutic molecules from 
fibrin gels is enhanced by increasing the fibrin content of the hydrogels (Jeon et al., 
2005, Bhang et al., 2007a), thus plastic compression may have further benefits not 
explored in this study. It should also be noted that fibrin gels typically degrade in vitro 
over the time frames used in this study. In order to prevent this degradation we added a 
protease inhibitor, Aprotinin, to the culture media. Previous work has also found that 
increasing the fibrin concentration (≈50 mg/mL) slows the degradation of the constructs 
in vitro (Eyrich et al., 2007). Thus it is possible that in addition to improved mechanical 
properties, the plastically compressed fibrin gels used in this study (≈84 mg/mL at day 
0) may also degrade slower.
Conclusions 
Plastic compression resulted in a significant increase in the compressive properties of 
fibrin gels without impairing cellular viability and subsequent extracellular matrix 
synthesis. The application of plastic compression to fibrin gels may provide a useful 
tool in tissue engineering applications that require an increase in gel density and 
mechanical properties immediately prior to implantation or at the onset of in vitro 
culture. 
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Figure 1. Plastic compression results in a stable increase in compressive modulus. (A) 
Plastic (permanent) strain of compressed gels at days 0 and 28. (B) Compressive 
modulus of uncompressed and compressed fibrin constructs at days 0 and 28. 
A
p<0.05
vs. uncompressed at the corresponding time-point. 
B
p<0.05 vs. uncompressed at day 0.
C
p<0.05 vs. compressed at day 0. 
Figure 2. Cell viability is not compromised by plastic compression. Images show 
representative sections of live (green) and dead (red) cells within the middle of 
uncompressed and compressed fibrin constructs at days 0 and 28. 
Figure 3. Significant levels of proliferation and ECM synthesis were found within 
uncompressed and compressed fibrin constructs. (A) Total DNA content per construct, 
(B) sGAG content per construct and (C) sGAG content normalised to DNA content.
A
p<0.05 vs. uncompressed at the corresponding time-point. 
B
p<0.05 vs. uncompressed
at day 0.  
C
p<0.05 vs. compressed at day 0.
Table 1. Fibrin gel properties. 
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